Life Sciences Litigation Insights: April 2022
CRA’s Life Sciences Litigation team provides periodic summaries of notable developments in litigation. In this issue, we share notable cases from 2021 and...
This website will offer limited functionality in this browser. We only support the recent versions of major browsers like Chrome, Firefox, Safari, and Edge.
With proven skills in complex cases and exceptional strength in analytics, CRA consultants have provided extensive guidance on domestic and international matters involving commercial damages and disputes. We have deep experience in all aspects of dispute resolution and international arbitration, including litigation as well as commercial and investment treaty claims.
We’ve acted in over $100 billion worth of cases for clients across virtually every major industry. Our experts can calculate damages, conduct valuations and investigations, and marshal considerable analytics expertise to guide clients and counsel through the entire dispute lifecycle. We’ve also provided testimony in hundreds of court cases and in international arbitrations across all major forums (ICC, ICDR, IUSCT, LCIA, PCA, SCC) and under UNCITRAL rules.
CRA’s Life Sciences Litigation team provides periodic summaries of notable developments in litigation. In this issue, we share notable cases from 2021 and...
In this eighth episode of Linklater’s “UK Competition Litigation Podcast Series,” CRA’s Oliver Latham joins Haidee Barratt and Alex Hannington to discuss the...
CRA is a proud sponsor of this event. Kris Swanson and Jordan Kraner are panelists during the program discussing the interplay between D&O insurance and the...
CRA is a proud sponsor of this event. Ken Mathieu and Jordan Kraner are panelists during the roundtable discussion titled “Inability to Pay: The Little-Known...